Cargando…

UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer

Detalles Bibliográficos
Autores principales: Shoji, Yoshiaki, Yokoe, Takamichi, Kobayashi, Yuta, Murakami, Tomohiro, Bostick, Peter J., Shiloh, Yosef, Hoon, Dave S. B., Bustos, Matias A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286529/
https://www.ncbi.nlm.nih.gov/pubmed/35839317
http://dx.doi.org/10.1002/ctm2.985
_version_ 1784748032264241152
author Shoji, Yoshiaki
Yokoe, Takamichi
Kobayashi, Yuta
Murakami, Tomohiro
Bostick, Peter J.
Shiloh, Yosef
Hoon, Dave S. B.
Bustos, Matias A.
author_facet Shoji, Yoshiaki
Yokoe, Takamichi
Kobayashi, Yuta
Murakami, Tomohiro
Bostick, Peter J.
Shiloh, Yosef
Hoon, Dave S. B.
Bustos, Matias A.
author_sort Shoji, Yoshiaki
collection PubMed
description
format Online
Article
Text
id pubmed-9286529
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-92865292022-07-19 UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer Shoji, Yoshiaki Yokoe, Takamichi Kobayashi, Yuta Murakami, Tomohiro Bostick, Peter J. Shiloh, Yosef Hoon, Dave S. B. Bustos, Matias A. Clin Transl Med Letter to the Editor John Wiley and Sons Inc. 2022-07-15 /pmc/articles/PMC9286529/ /pubmed/35839317 http://dx.doi.org/10.1002/ctm2.985 Text en © 2022 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Letter to the Editor
Shoji, Yoshiaki
Yokoe, Takamichi
Kobayashi, Yuta
Murakami, Tomohiro
Bostick, Peter J.
Shiloh, Yosef
Hoon, Dave S. B.
Bustos, Matias A.
UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
title UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
title_full UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
title_fullStr UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
title_full_unstemmed UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
title_short UBQLN4 promotes STING proteasomal degradation during cisplatin‐induced DNA damage in triple‐negative breast cancer
title_sort ubqln4 promotes sting proteasomal degradation during cisplatin‐induced dna damage in triple‐negative breast cancer
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9286529/
https://www.ncbi.nlm.nih.gov/pubmed/35839317
http://dx.doi.org/10.1002/ctm2.985
work_keys_str_mv AT shojiyoshiaki ubqln4promotesstingproteasomaldegradationduringcisplatininduceddnadamageintriplenegativebreastcancer
AT yokoetakamichi ubqln4promotesstingproteasomaldegradationduringcisplatininduceddnadamageintriplenegativebreastcancer
AT kobayashiyuta ubqln4promotesstingproteasomaldegradationduringcisplatininduceddnadamageintriplenegativebreastcancer
AT murakamitomohiro ubqln4promotesstingproteasomaldegradationduringcisplatininduceddnadamageintriplenegativebreastcancer
AT bostickpeterj ubqln4promotesstingproteasomaldegradationduringcisplatininduceddnadamageintriplenegativebreastcancer
AT shilohyosef ubqln4promotesstingproteasomaldegradationduringcisplatininduceddnadamageintriplenegativebreastcancer
AT hoondavesb ubqln4promotesstingproteasomaldegradationduringcisplatininduceddnadamageintriplenegativebreastcancer
AT bustosmatiasa ubqln4promotesstingproteasomaldegradationduringcisplatininduceddnadamageintriplenegativebreastcancer